Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,040 | 12,500 | 11,440 | 3,230 | 3,780 |
| Other current assets | 30 | 220 | 320 | 0 | 10 |
| TOTAL | $10,070 | $12,720 | $11,760 | $3,230 | $3,790 |
| Non-Current Assets | |||||
| PPE Net | 430 | 430 | 430 | 30 | 420 |
| Intangibles | 0 | 0 | 0 | 6,939 | 0 |
| Other Non-Current Assets | 6,450 | 6,620 | 6,790 | -20 | 7,120 |
| TOTAL | $6,880 | $7,050 | $7,220 | $6,950 | $7,540 |
| Total Assets | $16,550 | $19,380 | $18,590 | $10,230 | $10,960 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 90 | 60 | 200 | 220 | 110 |
| Accrued Expenses | 920 | 710 | 320 | 260 | 720 |
| Other current liabilities | 0 | 0 | 0 | 340 | 0 |
| TOTAL | $1,020 | $780 | $520 | $820 | $830 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,020 | $780 | $520 | $820 | $830 |
| Shareholders' Equity | |||||
| Common Shares | 80 | 70 | 70 | 60 | 60 |
| Retained earnings | -83,620 | -76,180 | -70,660 | -67,790 | -64,680 |
| Other shareholders' equity | 10 | 20 | 0 | 0 | 0 |
| TOTAL | $15,530 | $18,600 | $18,060 | $9,400 | $10,120 |
| Total Liabilities And Equity | $16,550 | $19,380 | $18,580 | $10,220 | $10,950 |